Le Lézard
Classified in: Health
Subjects: LEG, AVO

Domestic Gag Rule Reduces Birth Control Access for Over 45,000 Women Living in Rhode Island


WASHINGTON, July 28, 2020 /PRNewswire-PRWeb/ -- Data released by Power to Decide estimate that 45,290 Rhode Island women of reproductive age (13-44) in need of publicly funded contraception live in a county impacted by the Title X Family Planning Program "domestic gag rule."

The domestic gag rule requires health providers receiving Title X funds to withhold information from patients about abortion services and care. In addition, health centers are required to cease providing abortion care with non-Title X funds at sites that offer Title X supported services, such as contraceptive care, breast and cervical cancer screening and STI testing. The rule requires that abortion services, no matter how they are funded, be performed at a separate physical site, which is impossible for many health centers.

"The implementation of the domestic gag rule could impact over 45,000 women in need in Rhode Island," said Gillian Sealy, CEO, Power to Decide. "This federal rule exacerbates an already challenging contraceptive access landscape for women struggling to make ends meet. Even before the domestic gag rule went into effect, more than 64,000 low-income women in Rhode Island lived in contraceptive deserts, counties in which there is not reasonable access to the full range of contraceptive methods. As a result, these women face financial barriers related to transportation, child care and taking unpaid time from work; costs they incur just to get the contraception they need."

Data from Power to Decide show that 64,190 women living at or below 250% of the poverty level in Rhode Island live in contraceptive deserts, counties in which there is not reasonable access to a health center offering the full range of contraceptive methods. Of the 64,190 women in need, 2,310 live in counties without a single health center that provides the full range of methods. Nationally, more than 19 million U.S. women of low income live in contraceptive deserts.

In this challenging landscape, Rhode Island is taking steps to partially alleviate the impact of damaging federal policies and proactively expanding access to contraception in various ways. Rhode Island has already expanded Medicaid to adults with low-income, which helps decrease the percentage of uninsured women, and by extension, give them contraceptive coverage they need to live healthy lives. Further, Rhode Island has enacted state policies that extend the supply of prescription contraceptives. In addition, the Rhode Island legislature is considering bills to allow pharmacists to prescribe contraception and to protect insurance coverage of the full range of contraceptive methods, both of which would help expand access for more women. More information about these policies can be found here.

Power to Decide is a private, non-partisan, non-profit organization that works to ensure all people?no matter who they are, where they live, or what their economic status might be?have the power to decide if, when, and under what circumstances to get pregnant and have a child. Please visit us at http://www.PowerToDecide.org or follow us on Facebook and Twitter.

 

SOURCE Power to Decide


These press releases may also interest you

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIOŽ (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...



News published on and distributed by: